ARCHIVES

Decline In Breast Cancer Death Explained By Screening, Adjuvant Therapy, Study Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 11 | November 25, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006

Letter: Biostatistics Directors Invited To Share Concerns

June 7, 1996

Researchers Identify Five Genes Associated With Melanoma Risk

July 29, 2011

NIEHS Uses Gene Chips To Evaluate Chemicals.

March 3, 2000

Congress Agrees On Jackson Lab Support, But does Not Add Money; Earmarks Hit NCI Budget

October 27, 1989

In Brief: WHI Revises Protocol After Study Finds High Rate Of Endometrial Hyperplasia

January 27, 1995